πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12428406

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12419880

Companion diagnostic tool for mutant p53 reactivating compounds

PMV PHARMACEUTICALS, INC. Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11963953

Deuterated compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11938124

Combination therapy for treatment of cancer

PMV PHARMACEUTICALS, INC. Β· Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11926632

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814373

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11807644

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11731953

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11339141

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10640485

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10138219

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. Β· Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted